Health Care [ 5/12 ] | Biotechnology [ 25/74 ]
NASDAQ | Common Stock
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.
Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery.
The company develops EIP200 for central nervous system which is in preclinical trials.
The company was founded in 2010 and is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 25 | -0.80 Decreased by -110.53% | -0.63 Decreased by -26.12% |
| Nov 11, 24 | -0.55 Increased by +21.97% | -0.41 Decreased by -33.22% |
| Aug 9, 24 | -0.27 Increased by +82.62% | -0.31 Increased by +12.90% |
| May 14, 24 | -0.41 Increased by +79.60% | -0.39 Decreased by -5.13% |
| Mar 29, 24 | -0.38 Increased by +81.00% | -0.29 Decreased by -31.03% |
| Nov 13, 23 | -0.70 Increased by +66.02% | -0.95 Increased by +26.32% |
| Aug 8, 23 | -1.55 Increased by +49.72% | -2.90 Increased by +46.42% |
| May 15, 23 | -2.01 Increased by +39.64% | -1.91 Decreased by -5.24% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by -100.00% | -6.71 M Decreased by -183.86% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | -4.75 M Decreased by -321.06% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 3.29 M Increased by +N/A% | -2.32 M Decreased by -9.64% | Decreased by -70.44% Decreased by N/A% |
| Mar 31, 24 | 2.35 M Increased by +66.72% | -2.51 M Increased by +38.56% | Decreased by -107.12% Increased by +63.15% |
| Dec 31, 23 | 2.49 M Increased by +N/A% | -2.36 M Increased by +42.04% | Decreased by -94.85% Decreased by N/A% |
| Sep 30, 23 | 1.53 M Increased by +N/A% | 2.15 M Increased by +176.84% | Increased by +140.87% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -2.11 M Increased by +49.57% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 1.41 M Increased by +N/A% | -4.09 M Increased by +9.59% | Decreased by -290.68% - |